To select the most efficacious candidate and compare reference molecules, Tau antibodies targeting a variety of physiological and disease-selective epitopes were tested for their ability to neutralize human AD-PHF seeds in a co-incubation paradigm. This evidence concerns the gene MAPT and Alzheimer disease.